Render Target: STATIC
Render Timestamp:
3/24/2025, 7:29:17 AM EDT
3/24/2025, 11:29:17 AM UTC
Commit: a4bd4fb8969f29f780e26f33c272e3bb2f998a01
XML generation date: 2025-03-07 13:16:40.520
Product last modified at: 2025-03-21T23:15:07.210Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

RUFY3 (E6H5Z) Rabbit mAb #74223

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 53, 54
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    RUFY3 (E6H5Z) Rabbit mAb recognizes endogenous levels of total RUFY3 protein. This antibody detects multiple RUFY3 isoforms reported to be expressed by alternative splicing, including human RUFY3 isoform 1 and 2.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding His58 of human RUFY3 protein.

    Background

    RUN and FYVE domain-containing protein 3 (RUFY3) is an actin-binding protein that is enriched in the brain. RUFY3 was identified as a protein that is upregulated during neuronal polarization, which is important for proper neuron functioning (1). RUFY3 likely functions in regulating neuronal polarization by interacting with the neuronal cytoskeleton via actin filament-binding proteins, such as Fascin (2). RUFY3 undergoes various forms of posttranslational modifications, including CASP3-dependent cleavage and phosphorylation, which may modulate selective synaptic and axonal degeneration during brain development and neurodegenerative disease (3).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.